Jerome Zeldis Bernard's Insider Trades & SAST Disclosures
Jerome Zeldis Bernard's most recent trade in PTC Therapeutics Inc was a trade of 8,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jerome Zeldis Bernard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 18,500 (0%) | 0% | 0 | Common Stock | |
| Soligenix Inc | Zeldis Bernard Jerome | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 8,646 | 8,646 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Zeldis Bernard Jerome | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Bernard Jerome Zeldis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 12,000 | 26,500 (0%) | 0% | 51 | 612,000 | Common Stock |
| PTC Therapeutics Inc | Zeldis Bernard Jerome | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 02 Dec 2024 | 12,000 | 26,500 (0%) | 0% | 30.9 | 370,320 | Common Stock |
| PTC Therapeutics Inc | Jerome Zeldis Bernard | Director | Sale of securities on an exchange or to another person at price $ 51.44 per share. | 02 Dec 2024 | 8,813 | 17,687 (0%) | 0% | 51.4 | 453,341 | Common Stock |
| PTC Therapeutics Inc | Bernard Jerome Zeldis | Director | Sale of securities on an exchange or to another person at price $ 50.52 per share. | 02 Dec 2024 | 5,699 | 20,801 (0%) | 0% | 50.5 | 287,913 | Common Stock |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Sale of securities on an exchange or to another person at price $ 52.39 per share. | 02 Dec 2024 | 3,667 | 14,500 (0%) | 0% | 52.4 | 192,114 | Common Stock |
| PTC Therapeutics Inc | Zeldis Jerome Bernard | Director | Sale of securities on an exchange or to another person at price $ 52.42 per share. | 02 Dec 2024 | 3,187 | 14,500 (0%) | 0% | 52.4 | 167,063 | Common Stock |
| PTC Therapeutics Inc | Bernard Zeldis Jerome | Director | Sale of securities on an exchange or to another person at price $ 51.43 per share. | 02 Dec 2024 | 2,634 | 18,167 (0%) | 0% | 51.4 | 135,467 | Common Stock |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 20 Nov 2024 | 3,636 | 106,664 | - | 2.8 | 9,999 | Common Stock |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,818 | 1,818 | - | - | Warrant to Purchase Common Stock | |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 23 Aug 2024 | 10,000 | 103,028 | - | 2.5 | 25,000 | Common Stock |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2024 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Sale of securities on an exchange or to another person at price $ 38.24 per share. | 22 May 2024 | 20,000 | 14,500 (0%) | 0% | 38.2 | 764,800 | Common Stock |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.42 per share. | 22 May 2024 | 20,000 | 34,500 (0%) | 0% | 26.4 | 528,400 | Common Stock |
| PTC Therapeutics Inc | Bernard Jerome Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Bernard Jerome Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 14,500 (0%) | 0% | 0 | Common Stock | |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 38,136 | 38,136 | - | - | Stock Option (Right to Buy) | |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 26 May 2023 | 5,000 | 93,028 | - | 2.3 | 11,689 | Common Stock |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 10,500 (0%) | 0% | 0 | Common Stock | |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 46,154 | 145,285 | - | - | Stock Option (Right to Buy) | |
| Neximmune Inc | Jerome Bernard Zeldis | Executive VP of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 80,100 | 80,100 | - | - | Stock Option (Right to Buy) | |
| Nexgel Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 1.89 per share. | 25 Mar 2022 | 5,300 | 88,028 | - | 1.9 | 10,010 | Common Stock |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 6,500 (0%) | 0% | 0 | Common Stock | |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 29,126 | 29,126 | - | - | Stock Option (Right to Buy) | |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 14 May 2021 | 3,000 | 22,917 (0%) | 0% | 0.9 | 2,701 | Common Stock |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 14 May 2021 | 3,000 | 25,917 (0%) | 0% | 0.9 | 2,664 | Common Stock |
| Neximmune Inc | Jerome Bernard Zeldis | Executive VP of Research & Dev | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 5,882 | 5,882 | - | 17 | 99,994 | Common Stock |
| Neximmune Inc | Jerome Bernard Zeldis | Executive VP of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 351,016 | 351,016 | - | - | Stock Option (right to buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 1,650 | 3,300 (0%) | 0% | 0 | Common Stock | |
| Soligenix Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 15,228 | 15,228 | - | - | Stock Option (Right to Buy) | |
| Biosig Technologies Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 50,000 | 50,000 | - | - | Restricted Stock Units ("RSUs") | |
| Biosig Technologies Inc | Jerome Bernard Zeldis | Director | Purchase of securities on an exchange or from another person at price $ 10.49 per share. | 28 May 2020 | 1,000 | 107,944 (0%) | 0% | 10.5 | 10,489 | Common Stock |
| Biosig Technologies Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges